The chemical and physical properties of the high-molecular-weight glycoprotein (s%,, = 8S; V,. = VO on Sephadex G-200) with gastric antisecretory activity extracted from the urine of pregnant women were studied. Gel filtration in the presence of sodium dodecyl sulphate and sodium dodecyl sulphate/polyacrylamide-disc-gel electrophoresis indicated subunit mol
Inhibitors of gastric secretion have been found in human urine; these have been grouped under the general name of 'urinary gastric secretory depressant' or simply 'urogastrone' (Gray et al., 1940) , where the term 'gastrone' generically indicates the factor inhibiting all forms of gastric acid stimulation (Thomson, 1966) . Several authors (Friedman, 1951; Gregory, 1955; Mongar & Rosenoer, 1962; Morimoto & Yamamoto, 1969; Lawrence et al., 1971) described extraction procedures and partial chemical and physiological characterizations of purified antisecretory fractions. However, these studies did not lead to a clear elucidation of the chemical nature and physiological properties of the various isolated inhibitors. Sandweiss et al. (1938 Sandweiss et al. ( , 1939 observed that peptic ulcers rarely occur in women during pregnancy. This seemed to suggest that women might be protected under these circumstances by a hyperproduction of gastrone inhibiting the gastric secretion.
Indeed we succeeded in isolating from the urine of women at the third or fourth month of pregnancy (which corresponds to the period of maximal gastric hypokinesis and hypochylia) a high-molecular-weight glycoprotein showing a marked gastric antisecretory activity (Carrea et al., 1973) .
In the present paper we report the chemical and structural characterization of this inhibitor. The subunit structure and molecular weight in the presence of sodium dodecyl sulphate and the C-and N-terminal amino acids have been determined, and the carbohydrate moiety has been more thoroughly investigated. This work is a necessary preliminary to Vol. 153 a study of the biosynthesis and physiological mechanism of the glycoprotein, as well as to the development of an immunological assay.
Materials and Methods Preparation of the human urinary gastric inhibitor
Human urinary gastric inhibitor (hereinafter called the 'inhibitor') was obtained from the urine ofwomen at the third or fourth month of pregnancy as previously reported (Carrea etal., 1973 Needleman (1970) , was added (E/S ratio 1:12) and the digestion performed at 37°C. Portions (1.5ml) were remnoved at selected time-intervals, acidified to pH2 and freezedried. The residue was analysed with a Technicon autoanalyser.
Leucine aminopeptidase digestion. Inhibitor (16mg) was dissolved in 8 ml of 0.01 M-Tris/5mM-MgSO4 buffer, pH 8.5, containing 1.251umol of norleucine.
Leucine aminopeptidase (from pig kidney; type III, Sigma) was added (900,ug in 4ml of the same buffer;
E/S ratio of 1:18), after activation at 37°C for 30min. The digestion was performed at 37°C. Portions (2ml) were removed, acidified, freeze-dried, and analysed with the autoanalyser. Control experiments were performed by incubating the enzymes under the same conditions in the absence of substrate.
Amino acid analysis
Analyses were performed as previously reported (Carrea et al., 1973) .
Carbohydrate analysis
Total hexoses, methylpentoses, total hexosamines and sialic acid were determined as previously described (Carrea et al., 1973) . Glacosamine and galactosamine were analysed by ion-exchange chromatogaphy on the autoanalyser after sample hydrolysis with 3M-HCI in sealed-tubes under N2 at 105SC for 8h.
Individual neutral sugars were determined as trimethylsilyl derivatives by glc. (Sweeley et al., 1963) , after sample hydrolysis with 1 M-HCI at 105'C for 90min in sealed tubes under N2, and chromatography on a mixed-bed column consisting of equal amounts of Dowex 5OX8 and Dowex 1X2. Mannitol was added as the internal standard. Operating conditions were as follows: liquid phase 3.8% SE30; 140°-190°C; AT, 1.25°C/min; nitrogen flow, 25ml/ min.
Alkali treatment
Procedure L Inhibitor (5mg) was incubated in 2.5ml of 0.2M-NaOH/0.5M-NaBH4 at 370C for 60h in the dark (Nichols & Bezkorovainy, 1973) . Excess of borohydride was destroyed by acidification with acetic acid, and boric acid was removed by repeated evaporation under vacuum with a HCI/methanol mixture (1:1000, v/v). Glucosamine and galactosamine were deterimined, after acid hydrolysis, with the autoanalyser.
Procedure II. This procedure was essentially as described by Bhargava & Gottschalk (1967) . Inhibitor (15mg) was treated with 4ml of 0.2M-NaOH at 1000C. Portions (0.4ml) were collected at various times, cooled at 200C and treated -with 1.5ml of 0.1 M-borate/0.65M-NaBH4 buffer, pI H9, for 6-7h to reduce the released hexosamine.
Excess ofborohydride and boricacid waseliminated as described above. Bound hexosamine was determined after acid hydrolysis by the method of Elson & Morgan (1933) .
Gastric antisecretory activity in pylorus-ligated rats
This assay was performed as previously described (Lugaro et al., 1965) .
Results and Discussion
Subunit structure of the glycoprotein inhibitor Native inhibitor is characterized by a high value of the sedimentation coefficient (s2, =8 S) and is not retained by Sephadex G-200. Also, electrophoretic migration in highly porousF polyacrylamide gels is very slow (Carrea et al., 1973) . A quantitative estimate of the molecular weight of native material has not been made, but the above results clearly show the high-molecular-weight nature of the molecule. Carrea et al. (1973) showed that this urinary glycoprotein splits down to smaller fragments under mild alkaline conditions. This suggested that the inhibitor was composed of several subunits. This hypothesis is now confirmed by the present investigation of the behaviour of the glycoprotein in the presence of dissociating agents. Elution volume (ml) Fig. 1 . Gel-filtration profile of hmn urinary gastric inhibitor on Sephadex G-200 in the presence of sodium dodecyl sulphate Inhibitor (10mg) was subjected to gel filtration on a column (1.8cm x lOOcm) ofSephadex G-200, equilibrated with 0.5% sodium dodecyl sulphate in 0.05M-Tris/acetic acid buffer, pH8. The flow rate was 8ml/h. Before being applied to the column, the inhibitor was incubated in 3 ml of 2% (w/v) sodium dodecyl sulphate, pH8, at 37°C for 24h. experimental error) to that of native inhibitor, as shown in Table 1 .
After removal of sodium dodecyl sulphate by dialysis, and freeze-drying, peaks 1 and 2 were separately re-incubated in sodium dodecyl sulphate and subjected to gel-filtration through Sephadex G-200 as described in the legend to Fig. 1 . The material of peak 1 gave an elution profile similar to that reported in Fig. 1 (gel filtration of inhibitor) . The material of peak 2 gave a pattern of two peaks. The elution volumes in this case coincided with those of peaks 2 and 3 in Fig. 1 . Thus peak 1, which is eluted in the void volume (see Fig. 1 ), is composed of undissociated (or slightly dissociated) inhibitor. Peak 2 is a product of partial dissociation of the starting material and peak 3 represents the fully dissociated form.
When gel filtration was performed in the presence of0.25% /I-mercaptoethanol according to Kobayashi et al. (1972) The relative amounts of eluted glycoprotein corresponding to the three peaks depended on the incubation conditions. 8M-urea and 6M-guanidinium chloride were less effective dissociating agents of the glycoprotein than was sodium dodecyl sulphate.
Removal of sodium dodecyl sulphate from the material eluted in peaks 2 and 3 by means of exhaustive dialysis, and gel filtration through Sephadex G-25 (equilibrated with 0.01M-phosphate, pH7) caused re-association ofthe glycoprotein. In fact the material was eluted in the void volume of a column of Sephadex G-200 similarly equilibrated. This shows that the subunits of the inhibitor, formed in the presence of sodium dodecyl sulphate, can re-associate to highermolecular-w4ght species. Whether or not they revert to the same aggregated form of native inibitor is not known. The product of re-association retained about 30% of the biological activity of the native glycoprotein whern assayed for antisecretory activity ini the rat.
The evidence reported in the present paper strongly indicates that the native glycoprotein is composed of a single species of subunit whose molecular weight equals that of the material eluted as peak 3 in Fig. 1 .
Sodiun dodecyl sulphate/polyacrylamide-disc-gel electrophoresis showed two components, in agree;-ment with results obtained from sodium dodecyl sulphate-gel filtration. The mobility of the components was not changed by the addition of /1-mercaptoethanol. Therefore S-S bonds, if present, are intra-and not inter-chain.
Molecular weight determination for the subunits
The subunit molecular weight was measured by sodium dodecyl sulphate-gel filtration and sodium dodecyl sulphate/polyacrylamide-disc-gel! electro- Carboxypeptidase digestion of the inhibitor, previously incubated in the presence of sodium dodecyl sulphate, showed valine to be the C-terminal amino acid (Fig. 4) . The kinetics of the enzymic hydrolysis is consistent with the partial sequence Phe-Tyr-Leu-Val-OH. Approximately 1 mol of valine/mol of subunit was released on the basis of a subunit mol.wt. of 14500. This result confirms the molecular-weight determinations reported above. It also provides evidence of the homogeneity of the subunits, at least regarding their polypeptide backbone.
The results of the leucine aminopeptidase digestion 2 3 4 5 6 7 10-4 x Mol.wt. 10-4x Mol.wt. Fig. 3 . Plot of electrophoretic mobility against molecular weight of standard proteins electrophoresed in polyacrylanmide gels in the presence ofsodium dodecyl sulphate phoresis. As shown in Fig. 2 , the former method gave a subunit mol.wt. of 16000±1500. The product of partial disaggregation, eluted with peak 2 of Fig. 1 , had a mol.wt. of about 49000, corresponding to three times the subunit molecular weight. It should be stressed that these results represent only very approximate values, since it is known that several glycoproteins exhibit anomalous behaviour on gel filtration (Whitaker, 1963) . The subunit mol.wt. calculated from the mobility of the faster component in sodium dodecyl sulphate/polyacrylamide-disc-gel electrophoresis was 13000+ 1000 (Fig. 3 ). Table 2 . It is noteworthy that glycine is kinetically released in the same proportion as serine, threonine and valine during the enzymic digestion, despite the fact that the enzyme is markedly less specific for glycine than for all the other amino acids (Smith & Hill, 1960 Amino acid and carbohydrate composition of the glycoprotein inhibitor The acid character of the inhibitor is due to the significant amount of bound sialic acid (9 %) and also to the prevalence of acidic amino acids as shown in Table 1 . The glucosamine/galactosamine ratio is 4:1. Glucose, mannose and galactose are present in the ratio 2: 2: 3. Good agreement has been found between the quantitative data on hexosamines and neutral sugars obtained by the autoanalyser and g.l.c. respectively and the data obtained by colorimetric analyses. Although glucose is not frequently found in glycoproteins, it can be excluded that its presence in the inhibitor results from contamination of products of degradation of the Sephadex G-200 used for gel filtration. In fact, the glucose content of the inhibitor was unaffected by the use of a different molecular sieve such as Bio-Gel A-i.5m. Further, collagen-like contamination can be excluded because no hydroxylysine was found in the hydrolysates.
Effect ofalkali treatment on the inhibitor
All galactosamine appears to be involved in carbohydrate-protein linkages. This conclusion is based on two different lines of evidence.
Analyses of galactosamine after treatment of inhibitor with NaOH and NaBH4 (procedure I) have shown a 60% fall in content, and the formation of galactosaminitol; glucosamine was unchanged. The threonine, and to a less extent the serine content, suffers a decrease on alkali treatment. This decrease is greater than that observed for galactosamine on a molar basis. Thus it is likely that the alkali treatment also destroys some hydroxy amino acids (McGuire & Roseman, 1967) amine content after the alkali treatment (procedure II) have shown an approx. 20% decrease (Fig. 5) . This value coincides with the percentage of galactosamine relative to the total hexosamine in the inhibitor. It is therefore likely that all galactosamine present in the inhibitor is involved in O-glycosidic linkages.
As shown in Fig. 5 extended alkali treatment causes further and slower decrease in hexosamine content. This may be due to the hydrolysis of more stable bonds such as those involving glucosamine (Lee & Scocca, 1972) .
Concluding remarks
The effect of sodium dodecyl sulphate, as observed by gel filtration and electrophoresis, proves that the inhibitor undergoes reversible dissociation phenomena in solution. The mol.wt. of the subunits is estimated as 13000 by electrophoresis and 16000 by gel filtration. These values are within the range of uncertainty in molecular weight estimation of glycoproteins provided by the two techniques.
The measured molecular weight is confirmed by the experiments ofcarboxypeptidase A digestion showing that 1 mol of valine is released per 14000g of glycoprotein. Removal of the detergent from the dissociated glycoprotein resulted in re-aggregation of the subunits. This observation suggests that in aqueous solution the subunits are kept in some aggregated form by hydrophobic bonds. The strong tendency toward aggregation is evidenced by the observation that the incubation in 2% (w/v) sodium dodecyl sulphate does not promote complete dissociation of the inhibitor. Similar aggregation phenomena, in solutions containing detergents, also have been reported for other glycoproteins (Fletcher et al., 1970; Morawiecki, 1964; Janado etal., 1973) .
Several hypotheses can be made as to the site of synthesis of the inhibitor. Its dissociable nature and the size of the subunits are compatible with a possible origin above the renal glomerule. A duodenal origin of the inhibitor is suggested by studies performed on similar glycoproteins extracted from pig duodenum and urine (G. Carrea & G. Lugaro, unpublished work) .
On the other hand the great amount ofthe inhibitor present in the urine of pregnant women might suggest that the placenta is involved in the synthesis of this glycoprotein, at least during part of pregnancy.
Note added in Proof (Received 15 January 1976) Since this work was submitted, a paper has been published that describes the isolation from human urine ofan inhibitor of the gastric secretion (Gregory, 1975) . This inhibitor is not a high-molecular-weight glycoprotein like the inhibitor isolated by us, but a 53-residue polypeptide, and might be identified as the epidermal growth factor. Also, this peptide, though more active than the glycoprotein, is extractable in far smaller amount from urine. Thus at least two different inhibitors of gastric secretion are present in human urine.
